US Supreme Court Allows Telehealth and Mailing of Mifepristone to Continue

In a recent development, the US Supreme Court has made a ruling regarding access to mifepristone. The court has allowed the continuation of telehealth services and mailing of the medication. Further details on this decision can be found through the Guttmacher Institute, a local resource. They have released information on the Supreme Court's ruling, which may be of interest to local residents. For those seeking more information on the US Supreme Court's decision and its implications, the Guttmacher Institute's news release is available, providing additional context and details on the ruling.